Godavari Biorefineries shares surge 5% after securing Chinese patent for anti-cancer molecule, signaling strong growth prospects.

• Stock trading above key 50-day and 100-day moving averages since May, indicating an ongoing bullish trend.
• Securing a Chinese patent boosts confidence in the company’s ethanol-based chemical innovations for global pharmaceutical markets.
• YTD, Godavari Biorefineries stock gains around 4%, supported by steady investor sentiment and patent-driven optimism.